Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy

BACKGROUND: The major dose-limiting toxicity of paclitaxel, one of the most commonly used drugs to treat breast cancer, is peripheral neuropathy (paclitaxel-induced peripheral neuropathy). Paclitaxel-induced peripheral neuropathy, which persists into survivorship, has a negative impact on patient’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kober, Kord M, Schumacher, Mark, Conley, Yvette P, Topp, Kimberly, Mazor, Melissa, Hammer, Marilynn J, Paul, Steven M, Levine, Jon D, Miaskowski, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755139/
https://www.ncbi.nlm.nih.gov/pubmed/31486345
http://dx.doi.org/10.1177/1744806919878088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755139/
https://www.ncbi.nlm.nih.gov/pubmed/31486345
http://dx.doi.org/10.1177/1744806919878088

Ejemplares similares